z-logo
Premium
Kidney donor outcomes ≥ 50 years after donation
Author(s) -
Keys Daniel O.,
Jackson Scott,
Berglund Danielle,
Matas Arthur J.
Publication year - 2019
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.13657
Subject(s) - medicine , incidence (geometry) , population , diabetes mellitus , surgery , pediatrics , physics , environmental health , optics , endocrinology
Many living kidney donors (LDs) are young at donation; yet there are little data on long‐term LD follow‐up. We report on 66 LDs who donated ≥50 years ago: 22 (33.3%) are still alive (current age, 78.5 ± 7.25 years); 39 (59%) died (mean age at death, 74.2 ± 12.3 years); and 5 are lost to follow‐up (mean age at last contact, 68.7 ± 4.6 years). Those who died were older at donation ( P  < .001). Causes of death included 12 (30.8% of deaths) cardiovascular diseases, 9 (23.0%) respiratory failures, 5 (12.8%) malignancies and 4 (10.3%) infections, and 9 (23%) were unknown or miscellaneous. Forty‐nine living donors (74%) developed hypertension at a mean age of 59.9 ± 14.0 years; 12 (18%) developed diabetes at a mean age of 62 ± 19.4 years; and 11 (16.7%) developed proteinuria at a mean age of 60.6 ± 18.2 years—each at a similar incidence as seen in the age‐matched general population. At last follow‐up, the eGFR by CKD‐EPI (mean ± SD) for donors currently alive was 60.2 ± 13.4 mL/min/1.73 m 2 ; for those that died, 54.0 ± 21.5 mL/min/1.73 m 2 ; for those lost to follow‐up, 55.6 ± 7.5 mL/min/1.73 m 2 . ESRD developed in 2 (3.3%). SF‐36 quality of life health survey scores (n = 21) were similar to the age‐matched general population.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom